Clinical Trials Logo

Clinical Trial Summary

While cognitive therapy and exposure therapy are both proven to be effective for panic disorder and/or agoraphobia when outcome is assenssed up to one year after treatment (Gould et al., 1995) the scientific knowledge about long-term course of these disorders is still scanty. Although several long-term outcome studies have been conducted, the quality of these studies has been questioned.

The aim is to conduct a follow-up study of patients with either panic disorder with history of agoraphobia or agoraphobia without history of panic disorder. the patients were treated in a group format at Modum Bad during the years 1989 to 1997. Four subsamples will be included in the study. Subsample 1 (76 patients treated in 1989 and 1990) received combined cognitive and psychodynamic treatment. Subsample 2 and 3 (46 patients treated in 1992 - 1993) were allocated to either cognitive therapy or guided mastery treatment. Subsample 4 (45 patients treated in 1994 - 1996) received cognitive and schema focused therapy.

In the follow-up study the participants will be requested to complete the same self report measures as they completed at intake, discharge and at previous follow-up times. the participants will also be interviewed using the SCID-I and II as they were at the previous assessments.

The present sample is relatively unique in having received pure psychosocial experimental treatments. The very long term efficacy of cognitive therapy relative to behavioural treatmetns for agoraphobia can be evaluated, and the potential moderating effects of personality disorders can be assessed.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01446172
Study type Observational
Source Modum Bad
Contact
Status Completed
Phase N/A
Start date November 2009
Completion date November 2010

See also
  Status Clinical Trial Phase
Completed NCT00353470 - Comparison of Psychotherapy Programs to Treat Panic Disorder Phase 3
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Active, not recruiting NCT05124639 - Clinical Trial of a Group Self-management Support Program for Anxiety Disorders N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Completed NCT00734370 - Virtual Reality Exposure Therapy in Agoraphobic Participants N/A
Completed NCT00932919 - Thought Field Therapy and Cognitive Therapy for Agoraphobia N/A
Not yet recruiting NCT06315660 - VR Based Therapy to Treat Anxiety in Dual Diagnosis N/A
Completed NCT01928823 - Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia Phase 2
Completed NCT03684577 - Efficacy of Hypnotherapy for Agoraphobia N/A
Completed NCT01025908 - Cognitive Behavior Psychotherapy in Panic Disorder N/A
Completed NCT00202709 - Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder? N/A
Completed NCT03156556 - Improving Access to the Treatment of Anxiety and Depression Among Young Adults N/A
Recruiting NCT05510804 - Efficacy of an App-based CBT Featuring Virtual Reality for Anxiety Disorders N/A
Recruiting NCT03885453 - Construction of a Questionnaire on Panic Disorder and Agoraphobia
Completed NCT01928810 - Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia N/A
Recruiting NCT01323556 - Mechanisms of Panic Disorders Treatment Phase 2/Phase 3
Completed NCT00576719 - Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia Phase 2
Completed NCT03925987 - Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide N/A
Completed NCT03206437 - Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli N/A